The Adult Antiretroviral Treatment and Resistance Study (Tshepo)

NCT00197613 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

650

Enrollment

OTHER

Sponsor class

Conditions

AIDS
HIV Infection

Interventions

DRUG: (A) zidovudine, lamivudine and nevirapine
DRUG: (B) zidovudine, lamivudine and efavirenz
DRUG: (C) zidovudine, didanosine, and nevirapine
DRUG: (D) zidovudine, didanosine, and efavirenz
DRUG: (E) stavudine, lamivudine, and nevirapine
DRUG: (F) stavudine, lamivudine and efavirenz
PROCEDURE: Adherence Strategy Standard of Care (SOC)
PROCEDURE: Adherence Strategy Community-Based DOT

Sponsor

Harvard School of Public Health (HSPH)

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]